Moxifloxacin and gatifloxacin for initial therapy of tuberculosis: a meta-analysis of randomized clinical trials-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Moxifloxacin and gatifloxacin for initial therapy of tuberculosis: a meta-analysis of randomized clinical trials

Published:2016-01 Issue:1 Volume:5 Page:1-8
ISSN:2222-1751
Container-title:Emerging Microbes & Infections
language:en
Short-container-title:Emerging Microbes & Infections

Author:

Ruan Qiaoling¹²,Liu Qihui¹²,Sun Feng²,Shao Lingyun²,Jin Jialin²,Yu Shenglei²,Ai Jingwen²,Zhang Bingyan²,Zhang Wenhong²

Affiliation:

1. These authors contribute equally to the article.

2. Department of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai 200040, China

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Drug Discovery,General Medicine,Immunology,Microbiology,Parasitology,Epidemiology

Link

http://www.nature.com/articles/emi201612.pdf

Reference41 articles.

1. Global tuberculosis drug development pipeline: the need and the reality

2. Tuberculosis drug development: Progress, challenges, and the road ahead

3. Patient costs during tuberculosis treatment in Bangladesh and Tanzania: the potential of shorter regimens

4. Activity of moxifloxacin against mycobacteria

5. Sterilizing Activities of Fluoroquinolones against Rifampin-Tolerant Populations of Mycobacterium tuberculosis

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances and challenges of revolutionizing drug-resistant tuberculosis treatment;European Journal of Medicinal Chemistry;2024-11

2. Optimizing (O) rifapentine-based (RI) regimen and shortening (EN) the treatment of drug-susceptible tuberculosis (T) (ORIENT) using an adaptive seamless design: study protocol of a multicenter randomized controlled trial;BMC Infectious Diseases;2023-05-08

3. Marine Macrolides to Tackle Antimicrobial Resistance of Mycobacterium tuberculosis;Marine Drugs;2022-11-01

4. Moxifloxacin-Mediated Killing of Mycobacterium tuberculosis Involves Respiratory Downshift, Reductive Stress, and Accumulation of Reactive Oxygen Species;Antimicrobial Agents and Chemotherapy;2022-09-20

5. Emerging impact of triazoles as anti-tubercular agent;European Journal of Medicinal Chemistry;2022-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3